Revalidation for anaesthetists: will it be effective, evidencebased and practical?
In this issue of the journal, Roberts 1 provides us with a balanced and timely review of the existing processes that are utilised in comparable countries to determine and demonstrate 'fitness to practise' for doctors.
The Medical Board of Australia, in the 'conversation' begun in 2012 2 , has specifically chosen to use the term 'revalidation' as distinct from 'recertification' or 'appraisal' 3 . 'Revalidation' in its most complex iteration is the process used in the United Kingdom (UK) by the General Medical Council (GMC) to determine 'fitness to practise' utilising the four domains described in its Good Medical Practice document as its metric 1 . When announcing the Collaboration for the Advancement of Medical Education, Research and Assessment research, the President of the Medical Board of Australia, Dr Joanna Flynn, made the following comment: "Commissioning this research will help make sure that the decisions the Board makes in future about revalidation are effective, evidence-based and practical" 3 .
In a recent edition of Australian Doctor 4 , the assertion is made that a British Medical Association spokesman has suggested that revalidation is an "incredibly burdensome process" and "pretty much a waste of time". The same article claims that it costs around $165 million a year to run 4 .
In a recent personal reflection on the revalidation process in the UK, Dawda 5 makes the comment that, whilst his experience has been positive and that the revalidation process helps to assure patient safety, there are some caveats. These include a need to maintain an emphasis on the wider system and not just the individual practitioner, to consider the cost of revalidation in both time and money (and in particular the loss of time spent with patients) and finally to recognise that not all doctors will be successfully 'revalidated' 5 .
In a recent paper in the Medical Journal of Australia (MJA), Breen 6 asserts that what was a concern about the performance of the GMC (that is, a regulatory failure) appears to have turned into an issue for the entire medical profession; and that the GMC has sought to placate the profession by promoting revalidation as a means of honouring good doctors and implying that revalidation should be an unobtrusive celebration of their commitment and achievement 6 .
The strongest criticisms of revalidation have been of its sparse evidence base 1 . It has been claimed that it will not reliably detect poorly performing doctors, and many commentators have pointed out that it would not have identified Dr Harold Shipman 7 . There appears little doubt that the Shipman inquiry was a powerful catalyst for the eventual implementation of revalidation in the UK and that the inquiry "provided the profession and its regulators with an opportunity to affirm the public's entitlement to good doctoring for all" 8 .
In Australia, a number of mechanisms addressing the entire profession, which might be expected to have a beneficial effect on safety and quality of health care, have evolved in recent years, with the outcomes of these changes yet to be fully analysed and appreciated. Some of these changes include: in 2004 the former Australian Council for Safety and Quality in Health Care producing a standard for credentialling and defining the scope of practice of medical practitioners, for use in public and private hospitals 9 . This is incorporated into the Australian Commission on Safety and Quality in Health Care (ACSQHC) National Safety and Quality Health Service Standards 10 , which were mandated by health ministers, for all hospitals and day procedure services, in 2013. More local jurisdictions have also developed mandatory policy directives for credentialling and defining the scope of practice for medical practitioners 11 . Credentialling is specifically intended as a formal process to verify the qualifications, experience, professional standing and other relevant professional attributes of clinicians. This is to help confirm their competence, performance and professional suitability to provide safe, high quality services. The Standard requires that a reliable performance review process is in place for the clinical workforce.
Further, the National Registration Scheme gave rise to mandatory reporting, which was recently described by the President of the Medical Board of Australia as one of the most contentious aspects of the national law that governs medical regulation in Australia 12 . The Australian Health Practitioner Regulation Agency (AHPRA) revised the document in March 2014 13 . The aim of the mandatory notification requirements is to prevent the public from being placed at risk of harm. Any practice that is substantially substandard or is placing the public at risk necessitates a mandatory report of the practitioner to the Board.
For the specialty of anaesthesia, the Australian Medical Council has delegated the setting of the standard for continuing professional development (CPD) to the Australian and New Zealand College of Anaesthetists (ANZCA) 14 . This new Standard has been considerably altered of late and now incorporates a substantial practice evaluation component mandating several elements, which might include a peer review of practice or multi-source feedback 15 .
In Australia, the Committee of Presidents of Medical Colleges (CPMC) in its paper on revalidation 16 conceptualises it as a quality improvement tool based on a CPD framework to assess and improve competency, but with the capacity to identify outliers; it must build upon existing regulatory systems and reflect standard practice. Significantly, the CPMC suggests that a general principle is that any shift in policy towards a system of revalidation must involve all of the specialist medical colleges, working collaboratively with the regulator to achieve an agreed outcome 16 .
In a recent 'For Debate', Bolsin et al 17 propose that the routine application of a combination of technology and statistical analysis to monitoring individual performance during training and subsequent specialist practice makes revalidation easier and even irrelevant; arguing that only those practitioners not collecting performance data may need to undergo a formal revalidation process, because objective evidence of good practice would not be available for them 17 .
Recertification in the United States involves an examination process delivered via the Specialty Boards. In a Perspective article in the New England Journal of Medicine 18 , Teirstein contends that, although the American Board of Internal Medicine (ABIM) argues that there is evidence supporting the value of maintenance of certification (MOC), high-quality data supporting the efficacy of the program will be very hard, if not impossible, to obtain 18 . Additionally, he points out that while much of the US healthcare system is now focused on value, and physicians are working hard to provide better patient care at lower cost, MOC provides the opposite-an activity with no proven efficacy, at a high cost (MOC fees range from $2,715 to $3,335 every ten years; on top of these are costs for travel to testing centres, review courses, and time spent away from practice). He believes that, like the rest of the medical community, the ABIM should focus on efficacy, while cutting its costs and lowering its fees 18 .
There appears to be general agreement that a small minority of practitioners generates the majority of complaints and reports within Australia 19 . About 1.4% of 619,509 practitioners were the subject of a notification to AHPRA in 2013/2014 20 . There is also evidence that certain groups of practitioners can be identified as 'at-risk'. This is being explored by AHPRA in a research project between AHPRA, the National Health Profession Boards and the University of Melbourne. This is anticipated to take three years 21 . It is essential to ensure that the mechanisms currently in place to deal with this minority are robust and effective and that attention is directed to the 'at-risk' practitioner.
Given the above considerations, and noting that healthcare delivery by medical practitioners in Australia is organisationally quite different from the UK, it would seem (as Breen has suggested in his paper 6 ), that there is little to support the idea of simply transposing the UK revalidation system to Australia, and that despite some local failures of medical regulation and hospital governance, there has been no widespread loss of faith of the community in either its doctors or the current regulatory system. Moreover, it seems illogical (as Breen also asserts 6 ) and unnecessarily costly to introduce an additional layer of assessment of all doctors when there is more general agreement that most doctors strive to maintain and enhance their knowledge and skills and are rarely the subject of complaint.
A UK-wide collaboration of researchers known as UMbRELLA has been appointed by the GMC in 2015 to carry out an independent evaluation of revalidation over the next three years 22 . There appear to be reasonable grounds in Australia to allow some further time for evaluation of existing processes (that is, credentialling and scoping processes, mandatory notification and the existing and established CPD mechanisms) followed by a full evaluation of the UK experience and its outcomes before implementing any 'revalidation' process in Australia. If and when such a process is introduced, it should be 'effective, evidence-based and practical' 3 .
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